ArticleUrolithiasis2025
Kidney stones and oxidative stress. Types of papillary renal calculi.
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Oxidative stress, inflammation and kidney stones.Urolithiasis · 2025Article
- Effects of micro-channel negative pressure sheath percutaneous nephrolithotomy versus extracorporeal shock wave lithotripsy for renal stones: risk factors for postoperative complications.American journal of translational research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive oxygen species can promote the formation of kidney stones, and this process requires the participation of cells associated with the renal papilla. Here, we present a revised interpretation of the characteristics of the different types of renal papillary stones and the possible pathways responsible for their formation. We examined kidney stones from a biobank that contains 15,000 stones and identified five different types of papillary stones. Type I stones are calcium oxalate monohydrate (COM) stones that clearly have Randall's plaque but have no renal tubules near the stone-tissue junction. Type II stones are COM stones that have Randall's plaque and calcified renal tubules around the stone-tissue junction. Type III stones are calcium oxalate dihydrate (COD) stones that have a stone-tissue junction and calcified renal tubules. Type IV stones are COM stones containing important deposits of uric acid and/or Na or K urates that occur around stone-tissue junction, together with apatite phosphate, and may also contain bacterial imprints. Type V stones are small COM calculi that have no hydroxyapatite deposits at the stone-tissue junction. Oxidative stress of papillary tissues can generate heterogeneous nucleants that promote the crystallization of calcium phosphate and calcium oxalate, and urine composition determines the type of papillary stone ultimately develops. An active immune response can limit or prevent the development of these stones by eliminating the intra-tissue hydroxyapatite deposits or promoting the regeneration of the outer uroepithelium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.